SV

Street Verdict

Analyst Scorecard

A record of what Rajesh Palviya said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Natco Pharma, which has surpassed its 850 resistance zone with high volumes. The stock shows increased momentum with a 'band Bollinger' buy signal and favorable RSI across all time frames. It is well above its 20 and 50-day SMAs, indicating bullish sentiment. Expected upside is 950-1,020, with support at 855-810.”

Rajesh Palviya’s track record (trackable calls only): 95 graded calls · 95% CI 46–65%

Natco Pharma LtdBullishCalled 21 Nov 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Rajesh Palviya’s full track record